ZC3H12A (MCPIP1): Molecular characteristics and clinical implications

被引:15
作者
Cifuentes, Ricardo A. [1 ]
Cruz-Tapias, Paola [1 ]
Rojas-Villarraga, Adriana [1 ]
Anaya, Juan-Manuel [1 ]
机构
[1] Univ Rosario, Ctr Autoimmune Dis Res CREA, Sch Med & Hlth Sci, Bogota, Colombia
关键词
ZC3H12A; MCPIP1; Genetics; Apoptosis; Autoimmune diseases; Cardiac diseases; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ZINC-FINGER PROTEIN; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; LUPUS NEPHRITIS; ADIPOSE-TISSUE; MESSENGER-RNA; RENAL INJURY; CHEMOKINES; DISEASE;
D O I
10.1016/j.cca.2010.08.033
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Background: ZC3H12A is a gene whose absence is related to autoimmune disorders and to other phenotypical alterations. Methods: A comprehensive review of the structure, molecular functions and regulation of ZC3H12A gene and its protein MCPIP1 is done in order to understand their clinical implications. Results: ZC3H12A, at 1p34.3, has 9860 bp, six exons and 61 described SNPs. Eleven are non-synonymous thus leading to changes in MCPIP1, the protein encoded by ZC3H12A. MCPIP1 is induced by MCP-1 and IL-1 whose signals are transduced through the NF-k beta and MAPkinase pathways. This protein acts as an RNAse by degrading chemokine transcripts such as IL-1 as well as its own mRNA and as a transcription factor by reducing the expression of other chemokines induced by NF-k beta such as MCP-1. It also up-regulates genes involved in several differentiation processes and apoptosis. Therefore, ZC3H12A is an equilibrium gatekeeper that not only regulates its own inducers but also controls the regulation by degrading its own mRNA. Conclusion: Understanding ZC3H12A gives a comprehensive panorama that promises to improve our understanding of processes in which this gene is involved including autoimmune, infectious and cardiovascular diseases. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:1862 / 1868
页数:7
相关论文
共 55 条
[1]
Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares [J].
Amoura, Z ;
Combadiere, C ;
Faure, S ;
Parizot, C ;
Miyara, M ;
Raphaël, D ;
Ghillani, P ;
Debre, P ;
Piette, JC ;
Gorochov, G .
ARTHRITIS AND RHEUMATISM, 2003, 48 (12) :3487-3496
[2]
Signal Transduction Pathways Involved in Brain Death-Induced Renal Injury [J].
Bouma, H. R. ;
Ploeg, R. J. ;
Schuurs, T. A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) :989-997
[3]
Carvalho Brendan, 2008, J Vis Exp, DOI 10.3791/962
[4]
The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: From mechanism to treatment [J].
Clements, Janice E. ;
Mankowski, Joseph L. ;
Gama, Lucio ;
Zink, M. Christine .
JOURNAL OF NEUROVIROLOGY, 2008, 14 (04) :309-317
[5]
Das Lena, 2009, Curr Rheumatol Rep, V11, P218
[6]
Dawson J, 2003, EXPERT OPIN THER TAR, V7, P35
[7]
Role of smooth muscle cells in the initiation and early progression of atherosclerosis [J].
Doran, Amanda C. ;
Meller, Nahum ;
McNamara, Coleen A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (05) :812-819
[8]
Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes [J].
Gonzalez-Quesada, Carlos ;
Frangogiannis, Nikolaos G. .
CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (02) :131-138
[9]
Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients [J].
Harbo, HF ;
Datta, P ;
Oturai, A ;
Ryder, LP ;
Sawcer, S ;
Setakis, E ;
Åkesson, E ;
Celius, EG ;
Modin, H ;
Sandberg-Wollheim, M ;
Myhr, KM ;
Andersen, O ;
Hillert, J ;
Sorensen, PS ;
Svejgaard, A ;
Compston, A ;
Vartdal, F ;
Spurkland, A .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 143 (1-2) :101-106
[10]
The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis [J].
Hasegawa, Minoru ;
Sato, Shinichi .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 :3637-3647